Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
I mean yeah, the entire point is to maximize profit.
I was just curious if this was an inflated price due to “intellectual property rights” associated with the drug, which it appears to be.
I wonder how much it costs to actually manufacture. I feel like more people should understand that before they accept paying $8k or even $800 for a drug.
I mean yeah, the entire point is to maximize profit.
I was just curious if this was an inflated price due to “intellectual property rights” associated with the drug, which it appears to be.
I wonder how much it costs to actually manufacture. I feel like more people should understand that before they accept paying $8k or even $800 for a drug.
Junshi owns the IP and is licensing it out to Coherus.